Share on StockTwits

Varian Medical Systems (NYSE:VAR) SVP Kolleen T. Kennedy sold 1,416 shares of Varian Medical Systems stock on the open market in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $82.42, for a total transaction of $116,706.72. Following the transaction, the senior vice president now directly owns 6,236 shares in the company, valued at approximately $513,971. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

A number of analysts have recently weighed in on VAR shares. Analysts at Morgan Stanley reiterated an “underweight” rating on shares of Varian Medical Systems in a research note on Wednesday, May 7th. They now have a $76.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note on Friday, April 25th. They now have a $83.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. Varian Medical Systems has an average rating of “Hold” and an average price target of $84.14.

Varian Medical Systems (NYSE:VAR) traded up 1.11% on Wednesday, hitting $83.45. 313,720 shares of the company’s stock traded hands. Varian Medical Systems has a 52-week low of $65.70 and a 52-week high of $86.60. The stock’s 50-day moving average is $81.49 and its 200-day moving average is $81.22. The company has a market cap of $8.675 billion and a P/E ratio of 21.18.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $1.04 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.03 by $0.01. The company had revenue of $779.00 million for the quarter, compared to the consensus estimate of $772.84 million. During the same quarter in the prior year, the company posted $1.04 earnings per share. The company’s quarterly revenue was up 1.4% on a year-over-year basis. Analysts expect that Varian Medical Systems will post $4.30 EPS for the current fiscal year.

Varian Medical Systems, Inc, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.